T. Rowe Price Associates’s Pharvaris PHVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5M | Buy |
767,315
+181,228
| +31% | +$3.19M | ﹤0.01% | 1057 |
|
|
2025
Q1 | $9.2M | Buy |
586,087
+142,191
| +32% | +$2.23M | ﹤0.01% | 1129 |
|
|
2024
Q4 | $8.51M | Buy |
443,896
+118,408
| +36% | +$2.27M | ﹤0.01% | 1172 |
|
|
2024
Q3 | $6.03M | Sell |
325,488
-259,783
| -44% | -$4.81M | ﹤0.01% | 1241 |
|
|
2024
Q2 | $11M | Sell |
585,271
-172,644
| -23% | -$3.25M | ﹤0.01% | 1094 |
|
|
2024
Q1 | $17.5M | Sell |
757,915
-84,783
| -10% | -$1.96M | ﹤0.01% | 1004 |
|
|
2023
Q4 | $23.6M | Buy |
+842,698
| New | +$23.6M | ﹤0.01% | 914 |
|